Pharma’s Fight Against IRA ‘Will Not Relent,’ as Industry Looks to Supreme Court and Lobbies for Changes
Member Theresa Carnegie connected with Endpoints News about the pharmaceutical industry's continued legal challenges to the Inflation Reduction Act, even as the federal government has prevailed in about a dozen cases so far. AstraZeneca, one of the companies still pushing back, recently requested more time to petition the Supreme Court following a loss in the Third Circuit.
AstraZeneca’s persistence shows that “the manufacturers are not done fighting on this issue,” Theresa says. “They’re going to take it to whatever next level they can.”
Source